Concepedia

PM060184, a new tubulin binding agent with potent antitumor activity including P-glycoprotein over-expressing tumors

Marta Martínez, María José Guillen-Navarro, Benet Pera, Benjamin Pierre Bouchet, Juan Fernando Martínez-Leal, Isabel Barasoaı́n, Carmen Cuevas, José M. Andreu, Luis García‐Fernández, J. Fernando Dı́az,

Biochemical Pharmacology · 2014 · 55 citations · 35 references

DOI

Concepts

References

35

Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

Sunil Verma, David Miles, Luca Gianni et al. · New England Journal of Medicine · 2012 · 3.8K citations · Full text

, , +14

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

Anas Younes, Ajay K. Gopal, Scott E. Smith et al. · Journal of Clinical Oncology · 2012 · 1.5K citations · Full text

, , +17

Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

Barbara Pro, Ranjana H. Advani, Pauline Brice et al. · Journal of Clinical Oncology · 2012 · 990 citations · Full text

, , +15

Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death.

M A Jordan, K Wendell, Sheila M. Gardiner et al. · PubMed · 1996 · 783 citations

, , +17

Polewards microtubule flux in the mitotic spindle: evidence from photoactivation of fluorescence.

Timothy J. Mitchison · The Journal of Cell Biology · 1989 · 612 citations · Full text

, , +17